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ABSTRACT:  
Background: Approximately two thirds of the mortality following out of hospital cardiac 
arrest is related to devastating neurological injury. Previous small cohort studies have 
reported an impaired cerebrovascular autoregulation following cardiac arrest but no studies 
have assessed the impact of differences in oxygen and carbon dioxide tensions in addition to 
mean arterial pressure management.  
Methods: This is a protocol and statistical analysis plan to assess the correlation between 
changes in cerebral tissue oxygenation and arterial pressure as measure of cerebrovascular 
autoregulation, the tissue oxygenation index, in patients following out of hospital cardiac 
arrest and in healthy volunteers. The COMACARE study included 120 comatose survivors of 
out of hospital cardiac arrest admitted to ICU and managed with low-normal or high-normal 
targets for mean arterial pressure, arterial oxygen and carbon dioxide partial pressures. In 
addition, 102 healthy volunteers have been investigated as a reference group for the tissue 
oxygenation index. In both cohorts, the cerebral tissue oxygenation was measured by near 
infra-red spectroscopy.  
Conclusions: Cerebrovascular autoregulation is critical to maintain homeostatic brain 
perfusion. This study of changes in autoregulation following out of hospital cardiac arrest 
over the first 48 hours, as compared to data from healthy volunteers, will generate important 
physiological information that may guide the rationale and design of interventional studies. 
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1. INTRODUCTION 
Approximately two thirds of mortality following out of hospital cardiac arrest (OHCA) is 
related to devastating neurological injury 
1
. In contrast, only 10% of OHCA survivors who 
are discharged from hospital have neurological sequelae that make assistance with activities 
of daily living necessary 
2
, while the prevalence of cognitive dysfunction is two to three times 
higher 
3
. The cerebral blood flow (CBF) following return of spontaneous circulation (ROSC) 
after cardiac arrest typically involves a phase of initial hyperaemia (up to 20 minutes) 
followed by vasospasm and hypoperfusion (up to 12 hours) and then a gradual return to 
normal perfusion over 72 hours 
4-7
. The phase of hypoperfusion in particular represents a 
plausible window of opportunity for interventions to support CBF and ameliorate hypoxic 
ischaemic encephalopathy. 
The cerebral arteriolar resistance vessels are instrumental to maintain a homeostatic CBF by 
cerebrovascular autoregulation (CVAR) and are influenced by mean arterial pressure (MAP), 
carbon dioxide (PaCO2) and oxygen (PaO2) levels 
8,9
. Several studies have reported an 
impaired CVAR following cardiac arrest 
7,10-13
. An impaired CVAR renders the CBF flow 
passively pressure dependent and places the brain at risk of hypoperfusion or hyperperfusion 
as MAP decreases or increases, further compounded by hypoxia/hyperoxia and/or 
hypocapnia/hypercapnia.  
 
Near infrared spectroscopy (NIRS) can be used to measure cerebral tissue oxygenation 
(cStO2). The correlations between changes in cStO2 and MAP when analysed as a moving 
average over short periods of time provide the tissue oximetry index (TOx) (Figure 1). The 
TOx has been extensively investigated to monitor CVAR in different clinical contexts and it 
demonstrates a strong correlation with other established technologies to monitor CVAR
14-19
 . 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
In persons with normal CVAR, fluctuations in blood pressure do not cause any immediate 
marked changes in cStO2, whereas impaired CVAR results in concurrent MAP and cStO2 
changes.  
 
The TOx has previously been reported in small cohorts (20 to 51 patients) 
10,11,20
 of OHCA 
patients but no studies have assessed the impact of differences in oxygen and carbon dioxide 
tensions on CVAR during mechanical ventilation in ICU following OHCA. Furthermore, the 
effects of vasopressor use on CVAR is poorly understood. 
The aims of this study are to assess TOx and related variables of CVAR in a large cohort of 
comatose survivors of OHCA admitted to ICU and managed with low-normal or high-normal 
MAP, PaO2 and PaCO2 targets. We aim to characterise changes in CVAR and possible 
associations with neurological outcome and biomarkers or brain tissue injury. A control 
cohort of healthy adults (HA) of approximately the same size as the patient cohort will be 
used to address methodological variability of NIRS derived CVAR and to provide the 
reference for an ideal, optimal recovery following OHCA. In addition, we aim to typify the 
timing of impaired CVAR, patient characteristics and cardiac arrest factors associated with 
impaired CVAR and whether the incidence and severity of CVAR impairment varies 
according to the target temperature in patients undergoing targeted temperature management 
(TTM).   
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2. METHODS 
2.1 Study design and populations 
This is an observational, multicentre study of data collected prospectively in two independent 
cohorts referred to as OHCA (Out of Hospital Cardiac Arrest, approved by the ethics 
committees of the Northern Savo Hospital District, Finland, no. 295/2015, study protocol 
approved 23.2.2016, this post hoc study approved 12.2.2019,  and Midtjylland Region, no. 1-
10-72-163-16) and HA (Healthy Adult, approved by the South Western Sydney Local Health 
District Human Research Ethics Committee, HREC/14/LPOOL/135). No patient identifiable 
information is maintained in either database and data linkage is only feasible by the running 
study number reflecting the order of inclusion in the respective databases. Separate individual 
data files will be compiled for each patient including MAP and cStO2 values that do not 
include any information enabling identification of the individual patients (such as name, date 
of birth, initials, any exact dates or time for any event in the database, treating hospital or 
country).  
 
The OHCA cohort comprises patients admitted to six ICUs in Finland and one ICU in 
Denmark between March 2016 and March 2017. All patients had a witnessed OHCA of 
confirmed or suspected cardiac origin with ventricular fibrillation/tachycardia as the initial 
rhythm, had return of spontaneous circulation (ROSC) within 10-45 minutes but markedly 
impaired level of consciousness (GCS motor score < 5) and were admitted to ICU for full 
active management including mechanical ventilation and target temperature management 
(33-36˚C). Patients with in-hospital CA or CA of non-cardiac origin, non-shockable initial 
rhythms, no or minimal impairment of consciousness, deemed not for full active management 
or with an age <18 or >80 years were excluded. The full study protocol and the primary 
results are published 
8,9,21
. The HA cohort comprises adult healthy volunteers studied at 
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Liverpool Hospital ICU in conjunction with two clinical studies in 2014 and 2017. No 
participant had any history of cardiovascular or neurological disease or diabetes and refrained 
from the consumption of nicotine or caffeine on the day of the study. Results for a quarter of 
the cohort have been published 
22
.  
 
2.2 Data, calculated variables and outcomes 
1. Gender 
2. Age, prior health status and functional capacity 
3. Cardiac arrest characteristics and resuscitation factors 
4. Clinical characteristics in ICU for the first 48 hours 
 a. GCS after ROSC 
 b. APACHE II score 
5. Management in ICU for the first 48 hours 
 a. Targeted temperature management including the target temperature 
 b. Mean arterial pressure via arterial cannula 
 c. Three hourly arterial oxygen tension (PaO2) 
 d. Three hourly arterial carbon dioxide tension (PaCO2) 
 e. Frontal cerebral tissue oxygenation (cStO2) 
 e. Doses of sedative and vasoactive drugs 
6. Cerebrovascular autoregulation 
 a. Tissue oxygenation index (TOx) 
 b. Optimal tissue oxygenation index (OptTOx) 
 c. Mean arterial pressure for optimal tissue oxygenation index (OptMAP) 
 d. Upper mean arterial pressure limit for autoregulation (ULA) 
 e. Lower mean arterial pressure limit for autoregulation (LLA) 
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7. Outcome variables 
 a. Neuron-specific enolase (NSE) at 24 and 48 hours 
 b. S100B protein at 24, 48 and 72 hours 
 c. Electroencephalography (EEG) during the first 48 hours 
 d. Cerebral performance category (CPC) at six months following OHCA 
 e. Length of stay in ICU 
 f. Duration of mechanical ventilation 
 e. Length of stay in hospital 
 f. Discharge destination 
 g. Vital status at 30 days following OHCA 
 
Patients in the OHCA cohort were randomised according to a 2
3
 factorial design to normal-
low and normal-high strata of MAP (65-75 mm Hg vs. 80-100 mm Hg), PaO2 (10-15 kPa vs. 
20-25 kPa) and PaCO2 (4.5-4.7 kPa vs. 5.8-6.0 kPa) as per the pre-published study protocol 
21
. Subjects in the HA cohort had MAP manipulated by a randomised sequence of changing 
bed position, one hand immersed in ice water, mental arithmetic, Valsalva manoeuvre and 
hand grip manoeuvre.  
The cStO2 was measured in both studies by NIRS using bifrontal optodes attached below the 
hairline and with care taken to avoid the sagittal sinus medially and the temporalis muscle 
laterally. The mean of the hemispheric readings was used. Mean arterial blood pressure levels 
over time were measured with variable frequency (2-10 minutes). The moving Pearson 
correlation coefficient between cStO2 and MAP as measured at ten minutes intervals for the 
first 48 hours after admission to ICU will be analysed to generate TOx as previously 
described 
19
. The TOx approaches a range of 0 to -1 to indicate intact CVAR, and a range of 
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0 to 1 to indicate impaired CVAR. Mean tissue oximetry index values will be derived for the 
first 0-12 hours in ICU and then for the periods of >12-24 and >24-48 hours.  
The TOx is categorised into MAP bins of 5 mmHg and fitted to a second-order polynomial 
curve to calculate OptTOx and the OptMAP, i.e. the point of the most negative TOx 
indicating an optimal CVAR and the corresponding MAP (Figure 1). The MAP 
corresponding to a TOx threshold of 0.30
17
 will be calculated to represent the lower (LLA) 
and upper (ULA) limits of autoregulation, and to calculate the range of intact autoregulation 
(LLA-ULA) (Figure 1). The weighted multi-window method proposed by Depretiere et al. 
23
 
will be used in which multiple calculation windows are applied during a time frame ranging 
from 1 h to the total length of the recording (in 10 min increments) for each period above. A 
weighted average is calculated for each parameter (OptTOx, OptMAP, LLA, ULA and range) 
and will be reported for each period. Calculations of CVAR indices is performed using the 
ICM+ Brain Monitoring software (Version 8.3, University of Cambridge, Cambridge, UK). 
 
2.3 Outcomes 
The primary outcome is the comparison of changes in CVAR assessed by TOx against 
neurological outcome. The secondary outcomes include changes in biomarkers and extent of 
resource utilisation compared to changes in OptTOx, OptMAP, ULA, LLA and range. Both 
primary and secondary outcomes are explored in the groups according to the 2
3
 design for 
MAP, PaO2 and PaCO2 targets in OHCA. The feasibility outcomes compare the CVAR 
indices in OHCA against HA to investigate methodological variability and the degree of 
separation in CVAR between OHCA and HA subjects. 
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2.4 Samples size and power 
The OHCA cohort comprises 120 patients and the HA cohort comprises 102 subjects with all 
data capture procedures concluded. No formal sample size calculation has been performed 
specific to this protocol. The concentration range for biomarkers, the duration range for 
resource variables and the number of patients dying or with a poor neurological outcome 
according to the primary publications 
8,9
 are sufficient to allow for multiple CVAR variables 
to be included in regression analyses 
24,25
. All analyses in this observational study of already 
prospectively collected data will be considered exploratory and hypothesis-generating only.  
 
2.5 Statistics.  
Data will be presented as appropriate for categorical and normally or non-normally 
distributed variables based on the D’Agostino-Pearson omnibus normality test. Patient 
characteristics and outcomes will be reported according to the original 2
3
 factorial design 
with the CVAR indices separately for 0-12, >12-24 and >24-48 hours. A threshold of mean 
TOx >0.3 to indicate impaired CVAR at 0-12, >12-24 and >24-48 hours will be used to 
compare any differences in NSE, S100B, length of stay in ICU and in hospital using 
Student’s t-test and Mann-Whitney U test as appropriate. The CVAR indices will be 
separately reported for the dichotomous outcomes of NSE at 48 hour above or below the 
Youden index-based best cut-off value to predict poor neurological outcome in the 
COMACARE study, CPC1-2 vs. CPC 3-5 at six months, dead vs. alive at 30 days and mildly 
vs. moderately/severely abnormal EEG for 48 hours using receiver operating characteristics. 
We will also compare the incidence of CVAR in patient treated with TTM targeting 33°C (83 
patients) compared to those targeting 36°C (37 patients). A multivariable model will be 
created with factors available on hospital admission aiming at predicting the development of 
CVAR.   
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The associations between CVAR indices and continuous outcomes as dependent variables 
will be analysed by multiple linear regression with TOx and OptTOx included a priori. 
Multicollinearity will be assess using a variance inflation factor >3. The fit of the model will 
be reported by the F statistic and its P value and any independent variables will be reported 
by the unstandardized regression coefficients (B), their 95% confidence interval and P values.  
 
Associations between CVAR indices and dichotomous outcomes as dependent variables will 
be analysed by binary logistic regression analyses with TOx and OptTOx included a priori. 
The goodness of fit of the model using the Hosmer-Lemeshow test will be reported as well as 
the odds ratios and their 95% confidence intervals for any independent variables. 
A two-tailed P value <0.05 will be used to indicate statistical significance with appropriate 
corrections for multiple comparisons. All statistical analyses will be performed using the 
latest version of the SPSS statistical package (IBM Corporation, Armonk, NY, USA).  
 
2.6 Missing data 
The HA database contains no missing data and the degree of missing values in the OHCA 
database will be reported. Physiologically impossible values will be classified as missing and 
analyses based on the most complete datasets possible. No imputations for missing data will 
be performed. 
 
2.7 Reporting 
The results will be submitted to a peer-reviewed, international journals with a focus on the 
management of cardiac arrest patients in the ICU. The results will be reported according to 
the Strengthening the Reporting of Observational studies in Epidemiology (STROBE) 
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statement 
26
. This protocol has been developed as far as possible to comply with the 
STROBE statements and the reporting of diagnostic accuracy studies 
27
.  
 
3. DISCUSSION 
The NIRS technique to monitor CVAR holds clinical promise as it is continuous, non-
invasive and available at the bedside. With the assumption that other influences such as 
cerebral metabolic rate, haematocrit and oxygen diffusivity do not vary over short periods of 
time the cStO2 measured by NIRS serves as a surrogate measure of CBF. As a result, changes 
in cStO2 changes when correlated to changes in MAP allow the monitoring of CVAR. While 
the technique has been extensively reported, and validated against other methods to assess 
CVAR, monitoring CBF and the integrity of CVAR is not routinely applied in most ICUs 
managing OHCA patients. There is hence a limited body of evidence regarding NIRS to 
assess CVAR in comatose survivors of cardiac arrest admitted to ICU and the present study 
cohort is two to six times larger than any previously published and conducive to a 
comprehensive analysis of factors known to influence CVAR. 
 
The CBF following cardiac arrest is known to be variable at different points in time relevant 
to management in ICU. In patients with relatively intact CVAR following OHCA the upper 
limit of autoregulation is typically right-shifted meaning that a ‘normal’ MAP might still be 
insufficient to sustain CBF. Furthermore, the CVAR appears more effective above the upper 
limit of autoregulation compared to below the lower limit of autoregulation 
28
. There is a 
strong argument but limited evidence to individualise MAP targets in managing OHCA 
patients and this study aims to address this knowledge gap. An important feature of this study 
using NIRS is the assessment of CVAR rather than the cStO2 per se, since the cStO2 in itself 
does not appear to be associated with markers of neurological injury or outcome 
29
. The 
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median frontal cStO2 values were not different in the primary reports from the OHCA cohort 
8,9
. A recent study of 57 acutely comatose patients with a variety of neurological injuries 
admitted to a neurocritical care unit demonstrated that TOx correlated with GCS and the GCS 
motor score whereas the cStO2 value did not 
30
. 
 
The premise of this study is that indices of CVAR will vary between patients with varying 
degrees of neurological insult inflicted by cardiac arrest and resuscitation as measured by 
biomarkers, resource utilisation and patient centred clinical outcomes. Not only will the 
overall CVAR capacity as monitored by TOx be assessed but also the MAP for the optimally 
effective TOx. If it is accepted that the OptMAP represents an ideal individualised MAP 
target, this study enables a quantitative analysis of the importance of deviations from 
OptMAP during the time periods assessed. Better neurological outcomes defined by Glasgow 
Outcome Score were demonstrated when cerebral perfusion pressure was maintained close to 
OptMAP in an interventional study in head injured patients 
31
. In addition, the delineations of 
the LLA and ULA allows for a similar quantitative assessment of the time spent within and 
outside these limits in relation to the study outcomes. Previous studies have indicated that 
cerebral hyperaemia induced by a MAP above the ULA is associated with the development 
of delirium following cardiac surgery using cardiopulmonary bypass 
32,33
. While this study 
protocol cannot establish any causality between changes in CVAR and outcomes, any 
associations demonstrated may inform the design of future interventional studies. 
The inclusion of the HA cohort as a comparator is important to highlight the magnitude of 
CVAR changes observed in OHCA patients. The methodological issues and inherent 
variability for NIRS derived indices of CVAR have previously been contrasted to healthy 
subjects in a limited fashion 
10
. Comparisons of the OHCA and HA cohorts enable the 
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calculation of plausible effect estimates if CVAR indices would be targeted as primary 
outcomes in an interventional study. 
 
3.1 Limitations and strengths. 
Enrolment into the OHCA cohort was based on pre-published inclusion and exclusion 
criteria
21
 with less than ten percent of screened patients excluded for other reasons. The risk 
for selection bias in patients is hence deemed negligible. The NIRS monitoring was 
performed blinded to ICU staff and all CVAR calculations are performed off-line and post-
hoc and hence the risk for indication bias is considered insignificant. The much greater 
number of patients included compared to previous studies is conducive to assessing the 
variability of CVAR observed following OHCA and hence any spectrum bias is minimised. 
While the proprietary algorithms to generate cStO2 make direct comparisons using different 
NIRS monitors difficult
34
, the calculated correlation based on relative changes in cStO2 and 
MAP is considered less dependent on equipment and thus any classification bias is negated. 
All calculations of CVAR indices will be performed blinded to outcome data to minimise the 
risk for outcome bias. The statistical analyses will be performed by an independent 
biostatistician blinded to the outcomes of interest. 
 
4. CONCLUSION  
Cerebrovascular autoregulation is critical to maintain homeostatic brain perfusion. This study 
of changes in autoregulation following out of hospital cardiac arrest over the first 48 hours, as 
compared to data from healthy volunteers, will generate important physiological information 
that may guide the rationale and design of interventional studies. 
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